Cedara - unbekannt aber TOPwert der Med. Imaging systeme - 500 Beiträge pro Seite

[wwwillion]

Für Spezialisten und Liebhaber ein Wert, der sich lohnt.
Eine kanadische Firma, die in der Gewinnzone arbeitet und ein jährliches Gewinnwachstum von 35% prognostiziert.

Wurde im Konkurrenzvergleich an Platz 5 gewählt (von 100 Kandidaten) und mit 5 Sternen bewertet.

wwwillion


Formerly ISG Technologies, the company makes medical imaging software and support systems, which it either licenses or custom develops for other medical products and imaging companies. The company`s products present, manipulate, analyze, and store medical images that have been created through computed medical applications such as magnetic resonance imaging, digital X-rays, and nuclear scanning. It also provides contract engineering and technical support services. Cedara conducts business through locations in Canada, Japan, the UK, and the US. The company`s customers include GE, Hitachi, Kodak, Philips, and Siemens.

[breakeven]

Wo wird die Aktie gehandelt, WKN?

Gruß b.

[wwwillion]

breakeven,

in Toronto oder an der Nasdaq
(TSE: CDE NASDAQ: CDSW)

Share Price and Volume Information
(fiscal year quarterly closing price on the Toronto Stock ) Sept. Dec Mar. June
1997 4.15 4.15 3.45 3.45
1998 3.62 4.09 4.00 3.60
1999 3.15 5.00 4.95 5.75

http://www.cedara.com

Q2, 2000 Results: Cedara(TM) Software Reports Revenues Up 34%


TORONTO, Feb. 9 /CNW/ - (TSE: CDE/NASDAQ: CDSW) - Cedara Software,
(formerly called I.S.G. Technologies Inc.,) today reported financial results
for the second quarter. Revenues were $15.4 million for the second quarter of
2000 compared to $11.5 million in the same quarter last year, an increase of
34 per cent. Revenue growth resulted from strong sales in the core software
and services business and new revenue in the image-guided therapy business.
During the quarter, sales in the image management business were influenced by
a buying slowdown related to an industry-wide Y2K freeze on critical systems.
Net income per share was $0.04, compared to $0.02 per share in the second
quarter of 1999. Total earnings were $517,000 compared to $224,000 in the same
quarter a year ago, an increase of 131 per cent. The Company has posted eleven
consecutive profitable quarters. The positive earnings picture was achieved
concurrent with the successful launch of the Cedara brand in November at the
Radiological Society of North America (RSNA) trade show in Chicago. Cedara
gained important sales prospects at RSNA, and industry leaders including ADAC
Health Care, Marconi, Philips and TRW endorsed the benefits of outsourcing
medical imaging technology to Cedara.
Revenues for the six month period ended December 31, 1999 were $27.8
million, up 36 per cent from $20.5 million a year ago. Net income for the
period was $0.7 million, or $0.06 per share compared with $0.04 per share last
year.
During the quarter the Company invested in building brand awareness, in
increasing sales capability and maintained a high level of R&D activity;
consequently, operating expenses in the second quarter grew 21 per cent year
on year. Sales and marketing expenses were $4.3 million in the second quarter,
compared to $3.5 million last year, reflecting increased marketing efforts, an
expanded presence at RSNA and exhibits for the American Heart Association and
the Congress of Neurological Surgeons trade shows. R&D spending was $3.4
million compared to $2.8 million in the second quarter of fiscal 1999
reflecting our commitment to build innovative imaging technologies designed to
accelerate the solution development of our customers. General and
administrative expenses in the second quarter increased by $386,000, from $1.5
million to $1.9 million year on year, reflecting a larger employee complement.
With respect to the balance sheet, net cash balances increased $17.1
million during the quarter, reflecting the successful completion of the
Company`s private placement financing, which closed in November 1999. Proceeds
will go towards fuelling the Company`s high growth rate and to invest in
complementary companies and technologies. The Company intends to maintain a
strong cash balance to demonstrate stability to major customers who may choose
to significantly increase their business with Cedara.
Cedara Software is the world`s leading independent provider of medical
imaging software, serving major healthcare solution providers since 1987. The
Company`s software is incorporated into solutions for diagnostic imaging,
image management and image-guided therapy from world leaders in the healthcare
sector, including Aesculap, ADAC Health Care, Carl Zeiss, Inc., Elgems, eMed
Technologies, General Electric, Hitachi Medical, Image Devices, Marconi,
Mitsubishi Electric, McKesson/HBOC, Philips Medical Systems, Shimadzu,
Siemens, Toshiba, and TRW. The Company`s 446 knowledge workers in greater
Toronto, Tokyo and Silicon Valley develop, sell and service 2D, 3D and 4D
software applications, components, platforms and custom engineering solutions.
Cedara Software is listed on the Toronto Stock Exchange under the symbol
CDE and on the NASDAQ under the symbol CDSW. The company`s new ticker symbols
took effect on January 24, 2000 and previously were ISO/TSE and ISGTF/NASDAQ.
For more information, please see www.cedara.com.


<<
Cedara Software Corp.


wwwillion

[wwwillion]

Es ist an sich nicht meine Art, Meldungen ohne Quellenangabe zu posten. Ich habe jedoch eine Info aus zuverlässiger Quelle erhalten, daß schlechte Nachrichten von Cedara anstehen, die zu einem Kurseinbruch führen können.

Langfristig sind auch positive Meldungen in der Pipeline. Man sollte jedoch kurzfristig raus, um später erneut einzusteigen.

Im Augenblick: STRONG SELL

wwwillion